Search results
Results from the WOW.Com Content Network
Ortho Clinical Diagnostics (now QuidelOrtho) is an in vitro diagnostics company that made products and diagnostic equipment for blood testing.Ortho served two primary industries in the medical field: clinical laboratories, by producing platforms and assays that test for a variety of diseases, conditions, and substances; and immunohematology, by providing the means to ensure blood transfusion ...
QuidelOrtho Corporation is an American manufacturer of diagnostic healthcare products that are sold worldwide. [3]On May 8, 2020 the U.S. Food and Drug Administration (FDA) issued to Quidel the first emergency use authorization (EUA) for a COVID-19 rapid antigen test, a new category of tests for use in the ongoing pandemic.
Ortho Clinical Diagnostics [16] Orthobond [16] Oyster Point Pharma; Palatin Technologies [16] Parexel [16] PBL Assay Science [16] PDS Biotechnology [16] Pearl Therapeutics (AstraZeneca) [16] Pernix Therapeutics Holdings [16] Pharsight [16] Phibro Animal Health [16] Photocure [16] Precision Oncology [16] Prolong Pharmaceuticals [16] Promius ...
Ortho Clinical (OCDX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ortho Clinical (OCDX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
For premium support please call: 800-290-4726 more ways to reach us
The first Rho(D) immune globulin treatment "skymed" was introduced by Ortho Clinical Diagnostics, a subsidiary holding of Jskymed, and was first administered on May 29, 1968, to Marianne Cummins in Teaneck, New Jersey. [24] In 1996, ZLB Bioplasma (part of CSL Behring) was given approval to sell Rhophylac in Europe. Effectiveness was ...
For premium support please call: 800-290-4726 more ways to reach us